80 FR 8331 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 31 (February 17, 2015)

[Federal Register Volume 80, Number 31 (Tuesday, February 17, 2015)]
[Notices]
[Pages 8331-8332]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03092]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant and/or proposal applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R13 Conference Grant Review.
    Date: March 3, 2015.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Bratin K. Saha, Ph.D., Scientific Review 
Officer, Program Coordination and Referral Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Core Infrastructure & Methodological Research for Cancer 
Epidemiology Cohorts (U01).
    Date: March 12, 2015.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 6W032, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Viatcheslav A. Soldatenkov, Ph.D., M.D., 
Scientific Review Officer, Special Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Vacutubes to Preserve the Viability of Circulating Tumor 
Cells.
    Date: March 19, 2015.
    Time: 10:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Ivan Ding, M.D., Health Scientist Administrator, 
Program & Review Extramural Staff Training Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Predictive Biomarkers of Adverse Reactions to Radiation 
Treatment.
    Date: March 20, 2015.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Ivan Ding, M.D. Health Scientist Administrator, 
Program & Review Extramural Staff Training Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Small Grants Program for Cancer Research.
    Date: March 24-25, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Viatcheslav A. Soldatenkov, Ph.D., M.D., 
Scientific Review Officer, Special Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; AIDs Malignancy Consortium (AMC).
    Date: March 26-27, 2015.
    Time: 6:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Bratin K. Saha, Ph.D., Scientific Review 
Officer, Program Coordination and Referral Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Intervention and Surveillance Modeling.
    Date: April 1-2, 2015.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W554, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Christopher L. Hatch, Ph.D., Chief, Health 
Scientific Administrator, Program Coordination and Referral Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W554, Rockville, MD 20850, 240-276-
6454, [email protected].

    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction;

[[Page 8332]]

93.393, Cancer Cause and Prevention Research; 93.394, Cancer 
Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: February 10, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-03092 Filed 2-13-15; 8:45 am]
BILLING CODE 4140-01-P